Office-use compounding in Tennessee

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

Three cumulative conditions, and the middle one is the gateHigh confidence

Site and purpose — in the practitioner’s office, for administration. Commercial availability — only "when the product is not commercially available". And an order: a prescriber order is required even though no patient is named. The mechanism works because the statutory definition of the practice of pharmacy includes responsibility for compounding and dispensing prescription orders, so anything inside the definition is lawful pharmacy practice — and anything outside it is not.

The asymmetry is deliberate draftingMedium confidence

The "not commercially available" limiter attaches to the office-use limb and to the health care facility, emergency medical services and veterinary limbs — but not to patient-specific compounding or to anticipatory compounding on observed prescribing patterns. Tennessee treats office stock as a fallback for products a prescriber cannot otherwise obtain, rather than as a supply channel.

Tennessee is not veterinary-onlyHigh confidence

The veterinary limb is a separate paragraph. Human office use is squarely inside the definition, subject to its three conditions. This distinguishes Tennessee from the states whose only non-patient-specific pathway is an animal one.

The cleanest Tennessee path is not office use at allHigh confidence

The statutory definition of "dispense" expressly includes delivery of a prescription drug to a patient’s agent, "to include a licensed health care practitioner or a health care facility providing services or treatment to the patient or patients", pursuant to a prescriber’s lawful order. Delivering a PATIENT-SPECIFIC compounded drug to the practitioner is therefore dispensing, expressly. It needs no office-use theory, no commercial availability test and no wholesale licence.This is a genuinely useful routing fact and it is widely missed. The office-use limb is only needed for stock that is not tied to a named patient.

Non-patient-specific sterile stock is a different activity hereMedium confidence

Sterile manufacturing is defined as processing sterile products for wholesale or any other form of distribution, not pursuant to a prescription or medical order — and the wholesaler and manufacturer licensure exemption covers only dispensing pursuant to a medical or prescription order. Non-patient-specific sterile office stock is by definition not pursuant to such an order, so it falls inside the first and outside the second.Read together, those two provisions put a pharmacy shipping non-patient-specific sterile office stock into manufacturer and outsourcing-facility territory rather than pharmacy territory — except inside the narrow transfer window described below. This is a synthesis of two definitions rather than a rule anyone wrote, which is why it is not marked high.

The 5% cap, and all four of its limbsHigh confidence

Rule 1140-09-.01(3)(i) exempts sales, purchases or trades of a prescription drug by a pharmacy practice site to another such site or to authorized prescribing practitioners, except that the total gross dollar volume of such transfers shall not exceed five per cent of the total medical and prescription orders sales revenue of either the transferor or transferee pharmacy during any twelve consecutive month period. It is an exemption from licensure, not a grant of compounding authority. It is aggregate across all recipients. It is measured on gross dollar volume rather than units. And it binds either party — the receiving pharmacy’s revenue can breach it just as easily.

No office-use label legend existsHigh confidence

A case-insensitive search across the swept chapters for the usual legend phrases returns nothing. But the sterile label rule does textually contemplate a non-patient recipient: it requires the patient’s name if for outpatient use "or healthcare entity name", with the prescriber, pharmacy-site and directions elements dropping away for entity stock while the compounding, drug, dating and auxiliary-label elements do not.An unreconciled tension: the general dispensing label rule requires a patient name and makes no accommodation for entity stock. The two rules are not squared in the text.

Records and a quarterly report that is easy to missHigh confidence

Compounding records run two years and must carry the drug names and strengths, the sources and lot numbers of components, total dosage units, who prepared it, which pharmacist approved it, quality-control results, and the name of the practitioner or of the patient or healthcare entity who received the product. Separately, any licensed pharmacy compounding sterile products — except hospital pharmacies compounding for inpatients — must file a quarterly report with the Board listing the quantity of high-risk or batch sterile products compounded and dispensed, due by the fifteenth day of the month after each calendar quarter. A compounding pharmacy must also notify the Board within fourteen business days of any other agency’s disciplinary action, including a warning.

Last change — and a 2024 reversion that invalidates a lot of secondary writingHigh confidence

Tennessee’s sterile-compounding chapter was amended effective March 2024 and those amendments then EXPIRED effective 1 May 2024 under a public act, reverting the rules to their previous status. The sterile-compounding rules in force today are the pre-2024 text, so anyone citing the March 2024 version is citing rules that no longer exist. Beyond that there was no Tennessee rulemaking in 2025 or 2026 on compounding, outsourcing facilities, wholesaler licensure, physician office dispensing or office drug stock.Two dated items to watch: rules under a 2025 public act authorising a drug held "in the name of an authorized entity" have not been filed, and that would be the first Tennessee text authorising entity-held stock. And the wholesaler chapter still cites statute sections repealed in the 2023 recodification, so a re-promulgation should be expected.

Tennessee at a glance

Receiving 503B office stock in Tennessee

Tennessee asks an outsourcing facility for two credentials rather than one, and both come from the Board of Pharmacy. The receiving practice needs no permit at all — but the Board keeps inspection reach over a physician office that holds stock, and lawful custody runs through a named practitioner rather than the business.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Tennessee asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inHigh confidence

Two things. First, the licence itself: Rule 1140-01-.08(3) bars an out-of-state pharmacy practice site, manufacturer, outsourcing facility, oxygen supplier or wholesaler from conducting business in Tennessee until it obtains the required licence from the board. Second, a modifier: Rule 1140-01-.08(5) requires any entity licensed as, or applying as, a manufacturer or outsourcing facility that processes sterile drug products using aseptic processing to register and possess a modifier as a sterile manufacturer with the Board. The application requires proof of FDA registration and the most current inspection by that agency, a 24/7 contact reachable by the Board or the Department of Health in the event of a potential or actual public health threat, and a criminal background check for the owner or manager.The agency was confirmed negatively as well as positively: the Department of Agriculture’s licensing power runs to food, and it retains only inspection and embargo authority over drugs. Searching Tennessee law for the federal section numbers is a confident false negative — they appear nowhere. Search for "compounding of sterile drugs" and "sterile manufacturing" instead.

Does your practice need a permit?High confidence

No. A sweep of the pharmacy division, the medical and osteopathic boards, the controlled substance database rules, the pain management clinic chapter and the health facilities index found no permit a prescriber practice must hold to stock or possess drugs; every licensure requirement resolves to a pharmacy, manufacturer, outsourcing facility, oxygen supplier, wholesaler or third-party logistics provider. But the Board of Pharmacy keeps inspection reach: T.C.A. § 63-10-311 authorises it to inspect any site where drugs are stored or administered, while vesting authority over drug dispensing in a physician’s office in the board of medical examiners. Inspection reach without a permit requirement is an unusual combination and worth planning for.Custody runs through a person, not the business. It is unlawful for any person, firm or corporation to possess a legend drug except as provided, and the exemption is drafted around natural persons — it covers the licensed physician and "the drugs under the control of the physician ... in the practice of that person’s profession". The entity may own the practice and pay the invoice; "under the control of" is the operative concept.

Administer vs dispenseHigh confidence

The dividing line is remuneration. The medical board’s rule imposes its duties on physicians who elect to dispense medication for remuneration — federal controlled-substance regulations, a five-element container label, dispensing only to patients with whom a physician-patient relationship is established, and a separate log for controlled substances — and then expressly disclaims any intention to interfere with the physician’s right to administer drugs directly to a patient. So an administration-only office-stock practice triggers none of the dispensing apparatus.One duty binds both: it is a prima facie violation to prescribe or dispense without first performing and documenting an appropriate history and physical, a diagnosis, a therapeutic plan discussed with the patient, and assured follow-up. Note also that a clinic which advertises in any medium for pain management services of any type falls into the pain management clinic definition — a trigger with no drug threshold at all — and those clinics face a dispensing ban rather than a licence condition.

Scheduled (controlled) stockMedium confidence

Tennessee’s position here must be stated carefully, because the clean negative is wrong. The statute requires an annual controlled-substance registration from the board of pharmacy AND the appropriate occupational or professional licensing board, with a separate registration at each principal place of business or professional practice — and administering falls inside the trigger, because the criminal-code definition of "dispense" includes administering. But only the Board of Pharmacy implemented its half. A full-text sweep of the medical and osteopathic board rules found no registration requirement, no form and no fee line. So the practical stack for a Tennessee physician is a DEA registration plus enrolment in the controlled substance monitoring database.That is non-implementation, not an exemption: no rule exercises the statutory waiver, and the statutory duty sits there unimplemented. Confirm the position with the Board of Medical Examiners rather than relying on this paragraph. Monitoring-database enrolment is required of practitioners who prescribe or dispense controlled substances on more than fifteen days in a calendar year and hold a DEA registration, within 30 days of receiving the DEA number — per practitioner, keyed to the DEA number, not per location.

How to check a facility’s credential before you order is set out in how to place an office-use order.

What this page does not establish

• Cite the date-stamped rule files. The Secretary of State’s rules host also answers to undated filenames, and those serve a superseded compilation with an HTTP 200 — the undated introductory chapter returns a legacy document under an older numbering scheme, with no mention of outsourcing facilities anywhere in it. We hit this while verifying this page: the same rule number returned two materially different texts depending on the filename. The chapter index is the authority for which file is current.
• No official Tennessee Department of Health or Board of Pharmacy web page was reachable when this page was researched; every board address returned a not-found response. The outsourcing-facility credential rests on rule text alone, which is strong and unambiguous — but no application form, fee or observed licensing practice was confirmed.
• The practitioner-side controlled-substance position is a medium-confidence reading rather than a clean negative. The statute facially requires registration per location from the practitioner’s own board; neither practitioner board wrote the rule, form or fee; and no rule exercises the statutory waiver. Get the answer from the Board of Medical Examiners in writing before relying on it.
• Whether the rule reaching "any establishment or institution where prescription drugs are kept" captures a prescriber practice is unresolved, and it is the question to put to the Board.
• Statutory text here was read from a verbatim mirror rather than the official code host; rule text is from the official Secretary of State compilation. We searched no attorney-general opinions, board policy statements or meeting minutes — and the quarterly sterile report’s format is set by a Board policy document we have not read.
• Tennessee has no general drug-storage rule for a non-surgical practice. The only express storage standard sits inside the office-based surgery rule, and a sweep for storage terms across the medical board’s chapter found nothing of general application. For non-controlled office stock there is no Tennessee storage rule at all.